Aspiriant LLC
MET icon

Aspiriant LLC’s MetLife MET Stock Holding History

Aspiriant LLC’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,482
Closed -$210K – 444
2026
Q2 		$210K Sell
2,482
-1,542
-38% -$124K 0.01% 379
2026
Q1 		$285K Buy
4,024
+599
+17% +$44.8K 0.01% 287
2025
Q4 		$270K Buy
3,425
+214
+7% +$16.9K 0.01% 287
2025
Q3 		$264K Sell
3,211
-655
-17% -$51.5K 0.01% 269
2025
Q2 		$311K Buy
3,866
+530
+16% +$40.9K 0.01% 247
2025
Q1 		$268K Buy
3,336
+115
+4% +$9.6K 0.01% 249
2024
Q4 		$264K Buy
3,221
+3
+0.1% +$250 0.01% 249
2024
Q3 		$265K Buy
3,218
+17
+0.5% +$1.27K 0.01% 249
2024
Q2 		$225K Sell
3,201
-1,095
-25% -$78.2K 0.01% 262
2024
Q1 		$318K Buy
4,296
+88
+2% +$6.13K 0.01% 238
2023
Q4 		$278K Buy
4,208
+95
+2% +$5.94K 0.01% 254
2023
Q3 		$259K Buy
4,113
+297
+8% +$18.5K 0.01% 241
2023
Q2 		$216K Sell
3,816
-26
-0.7% -$1.44K 0.01% 267
2023
Q1 		$223K Buy
3,842
+98
+3% +$6.61K 0.01% 259
2022
Q4 		$271K Buy
3,744
+243
+7% +$17.4K 0.01% 225
2022
Q3 		$213K Buy
3,501
+113
+3% +$7.22K 0.01% 243
2022
Q2 		$213K Buy
3,388
+42
+1% +$2.78K 0.01% 258
2022
Q1 		$235K Buy
+3,346
New +$226K 0.01% 251
2018
Q2 		– Sell
-4,600
Closed -$211K – 257
2018
Q1 		$211K Buy
+4,600
New +$223K 0.02% 226

Other funds holding MET

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Nykredit A/S
Nykredit A/S Nordhavn, Denmark $27.5B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Aspiriant LLC's MET Position: Q3 2026 in Review

Aspiriant LLC sold out of MetLife (MET) in Q3 2026, closing a stake of 2,482 shares — an estimated $210K sold.

Aspiriant LLC first reported a position in MET in Q1 2018 and held it in 19 quarters. The position peaked at $318K in Q1 2024. 832 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Aspiriant LLC reported no remaining MetLife position as of Q3 2026 after selling out during the quarter.
  • Aspiriant LLC sold 2,482 MetLife shares in Q3 2026, an estimated $210K.
  • Aspiriant LLC first reported a position in MetLife in Q1 2018 and held it in 19 quarters.
  • Aspiriant LLC's MetLife position peaked at $318K in Q1 2024.
  • 832 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.